drugset / Trial / NCT05515588
A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The trial is intended to investigate the basic pharmacokinetics, excretion pathways and metabolism of BI 690517 and its metabolites.
Timeline
- Start
- 2022-09-19
- Primary completion
- 2022-11-17
- Completion
- 2022-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vicadrostat | Small molecule | — | Oral |
Indications
No indication recorded.